China Sees Flurry Of Activity On Avastin
Innovent’s Biosimilar Bevacizumab Approved As Bio-Thera And Henlius Advance
An approval for Innovent’s bevacizumab biosimilar has been granted in China, while other potential rivals to Avastin in the region have hit development milestones.
